John Paul II Medical Research Institute Logo

MIP Score

42

Med Research
General Medical Research

John Paul II Medical Research Institute

Mission

The John Paul II Medical Research Institute focuses on the ethical and cost-effective conduct of medical research to develop therapies and cures for various diseases. The Institute emphasizes the dignity of every human life and does not support embryonic stem cell research, instead prioritizing adult stem cell research.

Basic Information

Tax-Exempt

Address

2500 Crosspark Rd, Coralville, Iowa, 52241

View all Coralville charities

Founded in

2006

EIN

20-5239366

Total Assets

$509.2 thousand

UN Sustainable Development Goals Supported

This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.

At a Glance

COVID-19 Vaccine Research

COVID-19 Vaccine Research

Engaged in developing vaccines and therapies against COVID-19 using ethical research practices.

Stem Cell Education

Stem Cell Education

Provides educational outreach about the potential of adult stem cells.

Annual Reports

Annual Reports

Documents the financial and research progress of the institute over the years.

Impact Stats

$1,000,000

Financial Goal

Campaign for Cures Fundraising Goal for 2024

Aiming to raise $1,000,000 for COVID-19 vaccine and therapies research.

3

Milestones Achieved

2023 Scientific Milestones

Achievement in respiratory virus vaccine research and advancement in stem cell therapy technologies.

MIP Score (Beta)

The MIP Score is in beta! We'd love any feedback you may have.

The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.

Overall Score

42

28

/100

Program Expense Ratio

51.44%

4

/20

Program Revenue Growth

0.00%

2

/20

Leverage Ratio

0.3318

12

/20

Working Capital Ratio

0.6545

8

/20

Fundraising Efficiency

0

2

/20

Latest Filing Data: Form 990

Fiscal Year:2022

Source:Source: Self-reported by organization

Financial Details

Revenue

CategoryAmountPercentage
Contributions, Gifts, and Grants464.4K98.87%
Program Services4.953K1.05%
Investment Income3580.08%
Sales of Non-Inventory Assets00.00%
Other Notable Sources00.00%
Total Revenue469.7K100.00%